EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices

Phoebe Clark, Jayne Kim, Yindalon Aphinyanaphongs

JAMA Network Open · 05.07.2023 · 6 (7) · e2321792

DOI: 10.1001/jamanetworkopen.2023.21792 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JAMA Network Open, online erschienen am 05.07.2023. Verfasst von Phoebe Clark und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Informatics, NYU Langone Health, New York, New York. Hauptthemen laut MEDLINE: Artificial Intelligence, Device Approval. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The marketing of health care devices enabled for use with artificial intelligence (AI) or machine learning (ML) is regulated in the US by the US Food and Drug Administration (FDA), which is responsible for approving and regulating medical devices. Currently, there are no uniform guidelines set by the FDA to regulate AI- or ML-enabled medical devices, and discrepancies between FDA-approved indications for use and device marketing require articulation.

Objective

To explore any discrepancy between marketing and 510(k) clearance of AI- or ML-enabled medical devices. Evidence Review This systematic review was a manually conducted survey of 510(k) approval summaries and accompanying marketing materials of devices approved between November 2021 and March 2022, conducted between March and November 2022, following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. Analysis focused on the prevalence of discrepancies between marketing and certification material for AI/ML enabled medical devices.

Findings

A total of 119 FDA 510(k) clearance summaries were analyzed in tandem with their respective marketing materials. The devices were taxonomized into 3 individual categories of adherent, contentious, and discrepant devices. A total of 15 devices (12.61%) were considered discrepant, 8 devices (6.72%) were considered contentious, and 96 devices (84.03%) were consistent between marketing and FDA 510(k) clearance summaries. Most devices were from the radiological approval committees (75 devices [82.35%]), with 62 of these devices (82.67%) adherent, 3 (4.00%) contentious, and 10 (13.33%) discrepant; followed by the cardiovascular device approval committee (23 devices [19.33%]), with 19 of these devices (82.61%) considered adherent, 2 contentious (8.70%) and 2 discrepant (8.70%). The difference between these 3 categories in cardiovascular and radiological devices was statistically significant ( P < .001). Conclusions and Relevance In this systematic review, low adherence rates within committees were observed most often in committees with few AI- or ML-enabled devices. and discrepancies between clearance documentation and marketing material were present in one-fifth of devices surveyed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceDevice ApprovalUnited StatesHumansUnited States Food and Drug AdministrationMachine LearningMarketingSoftware

Autor:innen und Institutionen

  • Biomedical Informatics, NYU Langone Health, New York, New York.
  • New York University, New York, New York.

Zitieren

APA

Clark, P., Kim, J., & Aphinyanaphongs, Y. (2023). Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices. JAMA Network Open, 6(7), e2321792. https://doi.org/10.1001/jamanetworkopen.2023.21792

Vancouver

Clark P, Kim J, Aphinyanaphongs Y. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices. JAMA Network Open. 2023;6(7):e2321792. doi:10.1001/jamanetworkopen.2023.21792

BibTeX
@article{Clark2023,
  author = {Clark, Phoebe and Kim, Jayne and Aphinyanaphongs, Yindalon},
  title = {Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {7},
  pages = {e2321792},
  doi = {10.1001/jamanetworkopen.2023.21792}
}
Kostenlos starten →